Chevy Chase Trust
CRBU icon

Chevy Chase Trust’s Caribou Biosciences CRBU Stock Holding History

Chevy Chase Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Hold
10,000
– – ﹤0.01% 649
2026
Q1 		$19K Hold
10,000
– – ﹤0.01% 642
2025
Q4 		$15.9K Hold
10,000
– – ﹤0.01% 638
2025
Q3 		$23.3K Hold
10,000
– – ﹤0.01% 628
2025
Q2 		$12.6K Hold
10,000
– – ﹤0.01% 633
2025
Q1 		$9.13K Buy
+10,000
New +$13K ﹤0.01% 633

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chevy Chase Trust's CRBU Position: Q2 2026 in Review

Chevy Chase Trust held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 10,000 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Chevy Chase Trust first reported a position in CRBU in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.3K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Chevy Chase Trust held 10,000 shares of Caribou Biosciences worth $17.6K as of Q2 2026.
  • Chevy Chase Trust left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Chevy Chase Trust's portfolio in Q2 2026, its #649 holding.
  • Chevy Chase Trust first reported a position in Caribou Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Chevy Chase Trust's Caribou Biosciences position peaked at $23.3K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.